Latest News & Events
Procarta CEO attends the Berlin CMR Conference 2019
Procarta Biosystems Ltd. attended the Berlin Novel Antimicrobials and AMR Diagnostics Conference…Read more
PROCARTA ANNOUNCES €1.5 MILLION INVESTMENT FOR NEW CLASS OF ANTIBIOTICS TO COMBAT ANTIMICROBIAL RESISTANCE
Press Release - Stevenage, UK, 5th March, 2019 – Procarta Biosystems, a…Read more
"Antibiotic resistance plan to fight 'urgent' global threat"
BBC News report on British Government plans to combat antimicrobial resistance.
Procarta at BioSeed Life Science Investment Event
CEO of Procarta Biosystems Ltd. Dr. Andrew Lightfoot attended the BioSeed Early…Read more
Procarta Biosystems Ltd speak at BioInfect 2018
Procarta's Chief Scientific Officer, Professor Michael McArthur, was invited to speak at…Read more
NOW HIRING - Post-doctoral and Research Technician positions
Two positions are available to join a laboratory developing novel oligonucleotide antimicrobials,…Read more
Procarta Biosystems Ltd attend BioEurope, Copenhagen.
Dr Andrew Lightfoot (CEO) and Dr Martin Stocks (COO) attended BioEurope 24…Read more
Global concern over antimicrobial resistance
A compelling report on the fight against antimicrobial resistance and its history.
Procarta receives Seed investment of £600K
Procarta is pleased to announce it has completed the seed funding round…Read more
Appointment of Andrew Lightfoot as Procarta CEO
Procarta has appointed Dr. Andrew Lightfoot as CEO to define and execute…Read more